17 The impact of 3D printing is broadening with the first 3D printed pill

17 the impact of 3d printing is broadening with the

This preview shows page 9 - 11 out of 20 pages.

17 The impact of 3D printing is broadening, with the first 3D printed pill approved by the FDA in August 2015, and this technology now finding its way into prevention. 13 According to a recent study, 3D modeling and printing may help doctors to locate and identify plaque in the arteries to help prevent heart attacks. 14 A study at Heriot-Watt University in Scotland is testing drugs on 3D-printed brain tumor cells that grow and mimic the growth of real brain tumors. This should facilitate new treatments and speed up availability of vital new drugs. 15 While we believe technology in the first wave will benefit a wealthy, urban, health conscious population, it will only be a matter of time before it will spread to other demographics. Healthcare in emerging market, may even leapfrog western hospital-centric care models. For example in Rwanda, the digital healthcare platform Babylon provides patients with access to doctors through an online consultation app. 21 Predictive analytics 9 Pharma 2030: From evolution to revolution © 2017 KPMG International Cooperative (“KPMG International”), a Swiss entity. Member firms of the KPMG network of independent firms are affiliated with KPMG International. KPMG International provides no client services. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm. All rights reserved.
Image of page 9
© 2017 KPMG International Cooperative (“KPMG International”), a Swiss entity. Member firms of the KPMG network of independent firms are affiliated with KPMG International. KPMG International provides no client services. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm. All rights reserved. The new pharmaceutical playing fields Pharma tech An increasing number of pharmaceutical firms – and, indeed, medical device companies – are partnering and integrating with technology businesses. In a bid to tackle the huge and rising blight of diabetes, Sanofi and Verily, the life sciences unit of Google parent Alphabet, announced in September 2016 that they would invest approximately US$500 million in a joint venture to combine devices, software and medicine. 22 We believe medical device companies are leading the cooperation with tech companies. For example, in the diabetes space, one interesting partnership involves device giant Medtronic teaming up with tech firm Qualcomm, to develop a continuous glucose monitoring system that will also provide actionable insights to patients and providers. 23 Software is becoming more and more important in our lives, and healthcare is no exception. Another pharma tech alliance between Varian Medical Systems and Flatiron Health aims to develop cloud-based, electronic health records, data analytics and decision support software geared toward oncology patients. 24
Image of page 10
Image of page 11

You've reached the end of your free preview.

Want to read all 20 pages?

  • Summer '19
  • Management, KPMG International, KPMG International Cooperative

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture